Connection
Lisa Bero to Policy Making
This is a "connection" page, showing publications Lisa Bero has written about Policy Making.
|
|
Connection Strength |
|
 |
|
 |
|
4.352 |
|
|
|
-
Apollonio DE, Bero LA. Interpretation and use of evidence in state policymaking: a qualitative analysis. BMJ Open. 2017 02 20; 7(2):e012738.
Score: 0.518
-
Bero L. Systematic Review: A Method at Risk for Being Corrupted. Am J Public Health. 2017 Jan; 107(1):93-96.
Score: 0.509
-
Forsyth SR, Odierna DH, Krauth D, Bero LA. Conflicts of interest and critiques of the use of systematic reviews in policymaking: an analysis of opinion articles. Syst Rev. 2014 Nov 18; 3:122.
Score: 0.443
-
Magrini N, Robertson J, de Joncheere K, Bero L. On WHO's essential medicines process and transparency. BMJ. 2014 Sep 17; 349:g5637.
Score: 0.438
-
Jewell CJ, Bero LA. "Developing good taste in evidence": facilitators of and hindrances to evidence-informed health policymaking in state government. Milbank Q. 2008 Jun; 86(2):177-208.
Score: 0.283
-
Cook DM, Tong EK, Glantz SA, Bero LA. The power of paperwork: how Philip Morris neutralized the medical code for secondhand smoke. Health Aff (Millwood). 2005 Jul-Aug; 24(4):994-1004.
Score: 0.231
-
Boyd EA, Cho MK, Bero LA. Financial conflict-of-interest policies in clinical research: issues for clinical investigators. Acad Med. 2003 Aug; 78(8):769-74.
Score: 0.203
-
Chiu K, Thow AM, Bero L. Understanding the Dynamics of More Restrictive Medicines Policy: A Case Study of Codeine Up-Scheduling in Australia. Int J Health Policy Manag. 2023; 12:6872.
Score: 0.194
-
Joosse IR, Tordrup D, Bero L, Mantel-Teeuwisse AK, van den Ham HA. A critical review of methodologies used in pharmaceutical pricing policy analyses. Health Policy. 2023 Aug; 134:104576.
Score: 0.184
-
Bero LA, Montini T, Bryan-Jones K, Mangurian C. Science in regulatory policy making: case studies in the development of workplace smoking restrictions. Tob Control. 2001 Dec; 10(4):329-36.
Score: 0.180
-
Bero L. Implications of the tobacco industry documents for public health and policy. Annu Rev Public Health. 2003; 24:267-88.
Score: 0.180
-
Montini T, Bero LA. Policy makers' perspectives on tobacco control advocates' roles in regulation development. Tob Control. 2001 Sep; 10(3):218-24.
Score: 0.177
-
Bero LA. Improving the Quality of Systematic Reviews in Public Health: Introduction to the Series. Am J Public Health. 2020 11; 110(11):1601-1602.
Score: 0.167
-
Fabbri A, Lai A, Grundy Q, Bero LA. The Influence of Industry Sponsorship on the Research Agenda: A Scoping Review. Am J Public Health. 2018 11; 108(11):e9-e16.
Score: 0.145
-
Parker L, Williams J, Bero L. Ethical drug marketing criteria for the 21st century. BMJ. 2018 Apr 30; 361:k1809.
Score: 0.141
-
Nguyen NY, Bero L. Medicaid drug selection committees and inadequate management of conflicts of interest. JAMA Intern Med. 2013 Mar 11; 173(5):338-43.
Score: 0.099
-
Cook DM, Bero LA. The politics of smoking in federal buildings: an executive order case study. Am J Public Health. 2009 Sep; 99(9):1588-95.
Score: 0.077
-
Montini T, Bero LA. Implementation of a workplace smoking ban in bars: the limits of local discretion. BMC Public Health. 2008 Dec 08; 8:402.
Score: 0.073
-
Boyd EA, Bero LA. Assessing faculty financial relationships with industry: A case study. JAMA. 2000 Nov 01; 284(17):2209-14.
Score: 0.042
-
Parker L, Bero L, Gillies D, Raven M, Grundy Q. The "Hot Potato" of Mental Health App Regulation: A Critical Case Study of the Australian Policy Arena. Int J Health Policy Manag. 2019 03 01; 8(3):168-176.
Score: 0.037
-
Barnes DE, Bero LA. Industry-funded research and conflict of interest: an analysis of research sponsored by the tobacco industry through the Center for Indoor Air Research. J Health Polit Policy Law. 1996; 21(3):515-42.
Score: 0.030
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|